Company / Operating Income
Caris Life Sciences, Inc. Operating Income History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
$45.1M
FY2025
5-year range
-$319.6M / $45.1M
FY2023-FY2025
Trend
+117.5%
vs FY2024
Sector context
#89 of 156
Health Care
What the data says
At $45M, Caris Life Sciences, Inc.'s operating income ranks #89 of 156 in the Health Care sector. Improved from -$320M to $45M over the past 2 years.
Based on SEC 10-K filings.
$45M in FY2025.
Improved from -$320M to $45M over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#89 of 156 in Health CareTop 57% of 156This company $45.1M Sector average $733.1M
▼
-93.8% below sector average
Key checks
Key Insights
- In FY2025, operating income increased 117.5% year-over-year.
- Ranks #89 out of 156 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.08 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $45.1M | +117.5% |
| FY2024 | -$257.1M | +19.5% |
| FY2023 | -$319.6M | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026